NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event
July 15 2022 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a
pharmaceutical company developing and commercializing high-quality,
scientifically formulated eyecare and skincare products, announces
record sales of Avenova-branded products during Amazon’s Prime Day
event (July 12-13). Sales of Avenova-branded products during the
two-day event increased 27% over Prime Days 2021 and 48% over Prime
Days 2020, and reached a new one-day all-time high since the
product became available on Amazon.com in June 2019.
“We’re excited to break sales records during this year’s Prime
Day event. We believe consumers are feeling the financial pinch
from inflation and are seeking bargains on the products they
routinely purchase and use,” said Justin Hall, NovaBay CEO. “The
exceptionally strong reception to Avenova during this year’s Prime
Days together with our loyal customer base give us even greater
confidence for continued growth through the important Amazon.com
sales channel. Because dry eye is a chronic problem, we have many
lifetime customers.”
In addition to NovaBay’s flagship eyecare product Avenova Lid
& Lash Spray, discounts during Prime Days were available on
Avenova Lubricant Eye Drops and Avenova Moist Heating Eye Compress
Mask. In a first for Prime Days, NovaBay offered Avenova-branded
product bundles with three different bundles available to support
eye care for sufferers of bacterial dry eye. Avenova products are
highly rated on Amazon.com, with Avenova Lid & Lash Spray
receiving 4.5 out of 5 stars from more than 11,400 reviews,
including 85% of ratings at 4 stars or above.
About NovaBay Pharmaceuticals, Inc.: NovaBay
Pharmaceuticals, Inc. is a pharmaceutical company that develops and
sells scientifically created and clinically proven consumer
products for the eyecare and skincare markets. Avenova® is the most
prescribed antimicrobial lid and lash spray and DERMAdoctor is a
premium skincare brand offering more than 30
dermatologist-developed skincare products sold through traditional
domestic retailers, digital beauty channels and international
distributors.
NovaBay Pharmaceuticals Forward-Looking Statements Except
for historical information herein, matters set forth in this press
release may be forward looking within the meaning of the “safe
harbor” provisions of the Private Securities Litigation Reform Act
of 1995, including statements about the commercial progress and
future financial performance of NovaBay Pharmaceuticals, Inc. This
release contains forward-looking statements that are based upon
management’s current expectations, assumptions, estimates,
projections and beliefs. These statements include, but are not
limited to, statements regarding our business strategies, the
impact of Prime Days sales on the Company’s overall financial
performance, as well as generally the Company’s expected future
financial results. These statements involve known and unknown
risks, uncertainties and other factors that may cause actual
results or achievements to be materially different and adverse from
those expressed in or implied by the forward-looking statements.
Other risks relating to NovaBay’s business, including risks that
could cause results to differ materially from those projected in
the forward-looking statements in this press release, are detailed
in NovaBay’s latest Form 10-Q/K filings and Registration Statement
on Form S-1 filing with the Securities and Exchange Commission,
especially under the heading “Risk Factors.” The forward-looking
statements in this release speak only as of this date, and NovaBay
disclaims any intent or obligation to revise or update publicly any
forward-looking statement except as required by law.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on
Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s
Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220715005097/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com Investor
Contact LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024